Can AI help fight cancer?
Can AI diagnose cancer?
Can AI aid drug development?
Cool Clinical is a non-profit consortium of clinical and computational scientists, dedicated to developing Artificial Intelligence (AI) approaches to cancer.
We have, for the first time, developed successful AI-based systems for predicting the outcomes of clinical drug trials. This could lead to practical tools for precision medicine. This could also form the basis of innovative strategies for drug development, which improve efficacy and drug safety.
Machine learning can be applied to precision medicine, reducing costs and improving treatment. We present a case study on prostate cancer.
Machine learning can be applied to clinical-stage drug development, to signficantly reduce costs. We present a case study on prostate cancer.
Felix founded Cool Clinical, having worked in clinical trials, neuroscience and cancer.
Helena is a specialist in translational medicine and biomedical entrepreneurship.
Leonardo is an expert in deep learning and is currently working on cancer analytics.
Shreyash has a background in electical engineering and specialises in deep learning.
Xanthe has a background in experimental psychology and is exploring cancer diagnostics.
Murali is a computer scientist and is developing machine learning software
Divyashree is an electronic engineer and is developing machine learning software.